Background Comprehensive long-term data on atrial fibrillation trends in men and women
are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 …

Atrial fibrillation (AF) affects more than 33 million individuals worldwide 1 and has a complex
heritability 2 . We conducted the largest meta-analysis of genome-wide association studies (…

The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic
architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of …

Background Tools for the prediction of atrial fibrillation ( AF ) may identify high‐risk individuals
more likely to benefit from preventive interventions and serve as a benchmark to test novel …

BACKGROUND: Despite the widespread use of electrocardiographic changes to characterize
patients presenting with acute myocardial infarction, little is known about recent trends in …

Atrial fibrillation (AF) is a highly prevalent and costly health problem, with an estimated
incidence of 28 per 1000 person-years in the United States and an incremental national cost of …

Cardiovascular disease—a leading cause of morbidity and mortality among adults—is strongly
influenced by platelet function through acute thrombotic and atherogenic mechanisms. …

Background— Atrial fibrillation (AF) and heart failure (HF) frequently coexist and together
confer an adverse prognosis. The association of AF with HF subtypes has not been well …

Background MicroRNAs (miRNAs) are associated with cardiovascular disease and control
gene expression and are detectable in the circulation. Objective The purpose of this study …

Background Atrial fibrillation ( AF ) and heart failure ( HF ) are 2 of the most common
cardiovascular conditions nationally and AF frequently complicates HF . We examined how AF has …